Golden Arrow Merger Corp.

General Information

We intend to initially focus our search on identifying a prospective target business in the healthcare or healthcare-related infrastructure industries in the United States and other developed countries.

Timothy Babich serves as our CEO and CFO. Mr. Babich founded and manages Nexxus Holdings, an investment firm primarily dedicated to managing his investments. Nexxus opportunistically invests in private and public investments. At Nexxus, in late 2020, Mr. Babich merged two Ambulatory Surgery Center (ASC) software businesses, HST and Casetabs, and was personally the largest shareholder of Casetabs. The combination created the leading modern software suite for the fast-growing ASC market. Mr. Babich also is the co-founder of the RUNX1 Research Program, a medical foundation dedicated to finding a cure for an inherited predisposition to leukemia. 

Jacob Doft, the chairman of our board of directors, is the co-founder and CEO of Highline Capital Management.

(Note: Golden Arrow Merger Corp. priced its SPAC IPO on March 16, 2021, in line with the terms in its prospectus: 25 million units at $10 each to raise $250 million.)

Employees: 0
Founded: 2020
Contact Information
Address 10 E. 53rd Street, 13th Floor New York, NY 10022
Phone Number (212) 430-2214
Web Address
View Prospectus: Golden Arrow Merger Corp.
Financial Information
Market Cap $312.5mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol GAMCU
Exchange NASDAQ
Shares (millions): 25.0
Price range $10.00 - $10.00
Est. $ Volume $250.0 mil
Manager / Joint Managers BTIG
CO-Managers -
Expected To Trade: 3/17/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change